Biomerieux Logo

IDSA 2011 Survey Results

Of the physicians surveyed during the 49th annual meeting of the Infectious Disease Society of America (IDSA), held in Boston Oct. 20-22, 96% said that dramatically improving the speed of lab results is essential to curbing antibiotic resistance.

1) How important is the speed of results for a microbial identification test to patient outcomes?

1. Not Important (no responses)

2. Somewhat important

3. Very important

4. Critically important

2) How often are your updated about new tests and/or your tab lab's capabilities?

1. Never (no responses)

2. Rarely

3. Occasionally

4. Frequently

3) Do you currently know which diagnostic platforms are being used in your microbiology lab?

1. Yes

2. No

4) How concerned are you about antibiotic resistance?

1. Not concerned (no response)

2. Somewhat concerned

3. Very concerned

4. Gravely concerned

5) How involved are you in your hospital's antibiotic stewardship program?

1. Do not have stewardship program

2. Somewhat

3. I hold a board position

6) Over the last 12 months, have you noticed more antibiotic resistant pathogens?

1. Yes

2. No

7) Over the last 12 months, have you noticed more cases of sepsis?

1. Yes

2. No

8) If yes, circle the age groups where you have seen an increase in sepsis:?

1. Neonates

2. 18 and under

3. adults

9) Are you familiar with PCT as a new biomarker to aid in the dx of sepsis?

1. Yes

2. No

10) How important is turn-around-time when determining appropriate antimicrobial treatment?

1. Not important (no response)

2. Somewhat important

3. Very important

4. Critically important

11) If a technology were available that reduces time of microbial identification results from days to minutes, what kind of impact could that have on patient outcomes?

1. No impact (no responses)

2. Very little impact

3. Moderate impact

4. Significant impact

12) How strongly would you encourage your hospital to acquire such a technology if, and when, it is commercially available?

1. Not at all

2. Somewhat Strongly

3. Very Strongly

13) Are your currently aware of research into technologies, such as MS, that hold the potential to significantly speed up TATs for organism ID?

1. Yes

2. No

14) What if you could have organism ID results within minutes of a positive blood culture, although susceptibility would be available 8-12 hours later? Please qualify that speed:

1. No impact

2. Very little impact

3. Moderate impact

4. Significant impact

15) Do same day susceptibility results matter to you and why?

1. Guide therapy

2. Correct incorrect treatments

3. Avert misuse and overuse

16) Are you aware of the following technologies:

1. MALDI-TOF-MS

2. ESI-TOF-MS

3. qTOF-MS

4. PLEX-ID

5. GeneXpert

6. Etest

Videos

Watch the inspiring video of sepsis survivor Patricia Cragen and her family as they experience a once in a lifetime event at Strike Out Sepsis Day with the St. Louis Cardinals on August 31, 2015. Watch Video >

See highlights from the Second National Forum on Sepsis, held September 16, 2015 in Washington, DC, and learn more about the Rory Staunton Foundation’s initiatives to raise awareness and knowledge about sepsis. Watch Video >

Downloads

  • VIDAS® B•R•A•H•M•S PCT™ for the Clinician - Download
  • Procalcitonin: A Novel Biomarker for Bacterial Infections and Sepsis - Download
  • Procalcitonin Over Time - Download
  • Blood Culture: A Key Investigation for Diagnosis of Bloodstream Infections - Download